Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
Structure Therapeutics (NASDAQ: GPCR), a clinical-stage biopharmaceutical company focused on developing oral small molecule therapeutics for metabolic diseases, has announced its participation in three upcoming healthcare investor conferences.
The company will attend the Guggenheim SMID Cap Biotech Conference on February 5 in New York, featuring a fireside chat at 10:30 a.m. ET, the Leerink Global Healthcare Conference on March 10 in Miami with a fireside chat at 1:00 p.m. ET, and the Jefferies Biotech on the Bay Summit on March 11 in Miami for one-on-one meetings.
Webcasts of the fireside chats will be available on the company's investor relations website, with replays accessible for 90 days following the events.
Structure Therapeutics (NASDAQ: GPCR), un'azienda biofarmaceutica in fase clinica focalizzata sullo sviluppo di terapie orali a piccole molecole per le malattie metaboliche, ha annunciato la sua partecipazione a tre prossimi convegni per investitori nel settore sanitario.
L'azienda parteciperà al Guggenheim SMID Cap Biotech Conference il 5 febbraio a New York, con un incontro informale alle 10:30 ET, al Leerink Global Healthcare Conference il 10 marzo a Miami con un incontro informale alle 13:00 ET, e al Jefferies Biotech on the Bay Summit l'11 marzo a Miami per incontri individuali.
Le dirette streaming degli incontri informali saranno disponibili sul sito web delle relazioni con gli investitori dell'azienda, con le registrazioni accessibili per 90 giorni dopo gli eventi.
Structure Therapeutics (NASDAQ: GPCR), una empresa biofarmacéutica en etapa clínica centrada en desarrollar terapias orales de pequeñas moléculas para enfermedades metabólicas, ha anunciado su participación en tres próximas conferencias para inversores en el sector salud.
La empresa asistirá a la Guggenheim SMID Cap Biotech Conference el 5 de febrero en Nueva York, con una charla informal a las 10:30 a.m. ET, a la Leerink Global Healthcare Conference el 10 de marzo en Miami con una charla a la 1:00 p.m. ET, y a la Jefferies Biotech on the Bay Summit el 11 de marzo en Miami para reuniones uno a uno.
Las transmisiones de las charlas informales estarán disponibles en el sitio web de relaciones con inversores de la empresa, con repeticiones accesibles durante 90 días después de los eventos.
Structure Therapeutics (NASDAQ: GPCR)는 대사 질환을 위한 경구용 소분자 치료제를 개발하는 데 중점을 둔 임상 단계의 생명공학 회사로, 삼 개의 의료 투자자 회의에 참석할 것임을 발표하였습니다.
회사는 2월 5일 뉴욕에서 열리는 Guggenheim SMID Cap Biotech Conference에 참석하여 오전 10시 30분 ET에 fireside chat이 예정되어 있으며, 3월 10일 마이애미에서 열리는 Leerink Global Healthcare Conference에 오후 1시에 fireside chat이 진행됩니다. 그리고 3월 11일 마이애미에서 Jefferies Biotech on the Bay Summit에 1:1 미팅을 위해 참석할 예정입니다.
fireside chat의 웹캐스트는 회사의 투자자 관계 웹사이트에서 제공되며, 행사 후 90일 동안 재생이 가능합니다.
Structure Therapeutics (NASDAQ: GPCR), une entreprise biopharmaceutique en phase clinique axée sur le développement de thérapies orales à petites molécules pour les maladies métaboliques, a annoncé sa participation à trois prochaines conférences pour investisseurs dans le secteur de la santé.
L'entreprise assistera à la Guggenheim SMID Cap Biotech Conference le 5 février à New York, avec un entretien informel à 10h30 ET, à la Leerink Global Healthcare Conference le 10 mars à Miami avec un entretien informel à 13h00 ET, et au Jefferies Biotech on the Bay Summit le 11 mars à Miami pour des réunions individuelles.
Les webdiffusions des entretiens informels seront disponibles sur le site de relations investisseurs de l'entreprise, avec des rediffusions accessibles pendant 90 jours après les événements.
Structure Therapeutics (NASDAQ: GPCR), ein biopharmazeutisches Unternehmen in der klinischen Entwicklungsphase, das sich auf die Entwicklung von oralen kleinen Molekültherapeutika für Stoffwechselerkrankungen konzentriert, hat seine Teilnahme an drei bevorstehenden Gesundheitsinvestorenkonferenzen angekündigt.
Das Unternehmen wird am 5. Februar an der Guggenheim SMID Cap Biotech Conference in New York teilnehmen, wo um 10:30 Uhr ET ein informelles Gespräch stattfinden wird, an der Leerink Global Healthcare Conference am 10. März in Miami mit einem informellen Gespräch um 13:00 Uhr ET und am 11. März an dem Jefferies Biotech on the Bay Summit in Miami für Einzelgespräche teilnehmen.
Webcasts der informellen Gespräche sind auf der Website für Investorenbeziehungen des Unternehmens verfügbar, mit Aufzeichnungen, die 90 Tage nach den Veranstaltungen zugänglich sind.
- None.
- None.
SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will participate in multiple upcoming healthcare conferences being held in February and March.
Guggenheim SMID Cap Biotech Conference
| Format: | Fireside chat and 1x1 meetings | |
| Date/time: | Wednesday, February 5 at 10:30 a.m. ET | |
| Location: | New York, NY | |
| Webcast link: | https://wsw.com/webcast/guggen2/gpcr/2003892 | |
Leerink Global Healthcare Conference
| Format: | Fireside chat and 1x1 meetings | |
| Date/time: | Monday, March 10 at 1:00 p.m. ET | |
| Location: | Miami, FL | |
| Webcast link: | https://wsw.com/webcast/leerink38/gpcr/2218364 | |
Jefferies Biotech on the Bay Summit
| Format: | 1x1 meetings | |
| Date: | Tuesday, March 11 | |
| Location: | Miami, FL | |
The live and archived webcasts of the fireside chats will be accessible from the company’s website at https://ir.structuretx.com/events-presentations/events and replays will be available for 90 days.
About Structure Therapeutics
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world. For additional information, please visit www.structuretx.com.
Investors:
Danielle Keatley
Structure Therapeutics Inc.
ir@structuretx.com
Media:
Dan Budwick
1AB
Dan@1abmedia.com
FAQ
When and where will Structure Therapeutics (GPCR) present at the Guggenheim SMID Cap Conference?
What investor conferences will Structure Therapeutics (GPCR) attend in March 2025?
How long will Structure Therapeutics (GPCR) conference webcasts be available for replay?
Where can investors access Structure Therapeutics (GPCR) conference webcasts?
What type of presentations will Structure Therapeutics (GPCR) give at these conferences?
